Howard Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Buy
9,074
+3,434
+61% +$186K ﹤0.01% 356
2026
Q1
$354K Sell
5,640
-5,526
-49% -$442K 0.01% 262
2025
Q4
$1.06M Buy
11,166
+59
+0.5% +$5.78K 0.01% 238
2025
Q3
$1.08M Buy
11,107
+354
+3% +$36.7K 0.01% 223
2025
Q2
$1.15M Buy
10,753
+2,576
+32% +$261K 0.02% 205
2025
Q1
$825K Sell
8,177
-1,254
-13% -$126K 0.02% 210
2024
Q4
$842K Buy
9,431
+499
+6% +$43.9K 0.01% 233
2024
Q3
$749K Buy
+8,932
New +$704K 0.01% 240

Other funds holding BSX

Howard Capital Management's BSX Position: Q2 2026 in Review

Howard Capital Management increased its Boston Scientific (BSX) stake by 61% in Q2 2026, buying an estimated $186K and bringing the position to 9,074 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Howard Capital Management first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.15M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Howard Capital Management held 9,074 shares of Boston Scientific worth $387K as of Q2 2026.
  • Howard Capital Management bought 3,434 Boston Scientific shares in Q2 2026, an estimated $186K.
  • Boston Scientific made up ﹤0.01% of Howard Capital Management's portfolio in Q2 2026, its #356 holding.
  • Howard Capital Management first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Howard Capital Management's Boston Scientific position peaked at $1.15M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.